Alebund Pharmaceuticals Receives FDA IND Clearance...
Category : Clinical Trial Update 9 September 2026AP308 Moves Into Clinical Development Alebund Pharmaceuticals has received clearance from the U.S...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Novartis HARBOR Study of Del-desiran Misses Primar...
Category : Clinical Trial Update 9 September 2026Phase III Study Does Not Show Statistically Significant Improvement on Primary Endpoint Novartis...
Rezubio Completes First Cohort Dosing in Phase 1 T...
Category : Clinical Trial Update 9 September 2026RZ-520 Moves Into Clinical Development for Chronic Respiratory Diseases Rezubio has announced tha...
Argo Biopharma Reports Updated Phase 2 Data for BW...
Category : Clinical Trial Update 8 September 2026Investigational siRNA Therapy Shows Durable Reduction in HAE Attacks Argo Biopharmaceutical Co.,...
Tangram announces progression to patient cohorts i...
Category : Clinical Trial Update 7 September 2026Tangram Therapeutics (Tangram), a company committed to unlocking transformative RNAi medicines for m...
Latest Newsletter Post
-
Rezubio Completes First Cohort Dosi..
9 September 2026
-
Novartis HARBOR Study of Del-desira..
9 September 2026
-
Alebund Pharmaceuticals Receives FD..
9 September 2026
-
Argo Biopharma Reports Updated Phas..
8 September 2026
-
Inhibrx To Host Webcast Presentatio..
7 September 2026
